Case report of secondary T-cell deficiency following the AstraZeneca COVID-19 vaccine
We present a case of secondary T-cell deficiency particularly affecting CD4 T cells, along with the emergence of chronic spontaneous urticaria in a patient following COVID-19 vaccination. The condition was partially managed with omalizumab after initial first-line therapy proved ineffective.
Authors
- Amin Esmailian
- Marsus Pumar
- Sara Barnes
Institutions
- Monash Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Journal of Allergy and Clinical Immunology Global
- Published
- 2024-09-06
- DOI
- https://doi.org/10.1016/j.jacig.2024.100339
- Primary Topic
- Blood disorders and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00